Small, Medium API-Makers In Indian Economy Squeeze Seen Merging
This article was originally published in PharmAsia News
Executive Summary
Small and medium-size makers of active pharmaceutical ingredients in India are suffering from an increase in costs they are unable to pass on to buyers. Many of the companies also are being hurt by dampened enthusiasm for their shares, adding to the squeeze. As a result, industry analysts see a flurry of consolidation in the API-making industry in India by the middle of next year. But at least one analyst sees that as an opportunity for healthy companies to buy the smaller firms. (Click here for more